AmblyopiaEn Español (Spanish Version)
Amblyopia is a condition that occurs when there is a reduction of vision in one eye that is not correctable with glasses. Amblyopia, which is often called “lazy eye,” is most common in infants and children, but it can also occur in adults. Amblyopia is not contagious.
There are two common types of amblyopia:
- Anisometropic amblyopia
occurs when the vision in one eye differs from the other. This is often caused by a large difference in eyeglass prescription. The difference may be caused by one eye being more nearsighted or farsighted than the other or caused by large differences in astigmatism.
In general, people who have anisometropic amblyopia are often asymptomatic (showing no signs of the condition).
- Strabismic amblyopia
occurs when there is a visible misalignment (crossing) of one eye.
Copyright © Nucleus Medical Media, Inc.
If you suspect that you or your child has this condition, contact the doctor. The sooner amblyopia is treated, the more favorable the outcome.
Amblyopia is caused when the brain prefers (favors) one eye to the other. The brain’s preference (liking) for one eye over the other can weaken and reduce vision in the eye that is less used.
There are no apparent genetic or environmental factors that can be attributed to causing amblyopia.
A risk factor is something that increases your chance of getting a disease or condition.
The following factors increase your chances of developing amblyopia. If you have any of these risk factors, tell your doctor:
Age: children nine years of age or younger with:
- Crossed eyes
A large difference in sight between the two eyes (nearsighted, farsighted, or astigmatism) that may
- Not be noticed
- Be detected by a large difference in eyeglass prescription
- Visual blockage such as a cataract, droopy eyelid, or corneal scarring
The symptoms for amblyopia vary from person-to-person. Some people might be asymptomatic (showing no signs of the condition) while others are symptomatic (showing signs of the condition).
If you experience any of these symptoms do not assume it is due to amblyopia. These symptoms may be caused by other, less serious health conditions. If you experience any one of them, see your physician.
- A droopy (the inability to fully-open) eyelid that blocks the pupil
- Blurry vision
- Excessive squinting or closing of the eyes
- Repeatedly closing of one eye in bright sunlight
- A misalignment (crossing) of one eye, generally the eye that is less used will excessively turn toward the nose
Your doctor will ask about your symptoms and medical history, and perform a physical exam. You may also be referred to an ophthalmologist, a doctor who specializes in the medical and surgical treatment of eye disorders and vision measurement. Since amblyopia tends to occur in young children, the types of tests an ophthalmologist will perform will be determined by the patient’s age and their ability to respond to the ophthalmologist.
Tests may include the following:
- Visual acuity assessment testing (VAT)—such as the Lea Symbols test that is used to assess distant vision.
- Cycloplegic refraction test—which is performed to determine how the eyeball displays and receives images produced by the lens of the eye. To perform the test, eye drops are used to dilate (widen the pupil) for a better view of the eye. To determine the direction of light the eye receives and displays, the dilating drops briefly paralyze (impair movement or make inactive) the eye muscles that control focusing.
- Retinoscopy which allows an eye specialist to determine a preverbal child’s eyeglass prescription
- Prisms to determine the amount of crossing between the two eyes if present
Talk with your doctor about the best treatment plan for you. First, correction of any visual obstructions, such as cataracts, needs to be accomplished. In addition, the doctor will treat any significant visual abnormalities or defects, such as excessive nearsightedness, farsightedness, or astigmatism with glasses or contact lenses. The child may need to be encouraged to use the amblyopic eye.
Treatment options include the following:
Atropine drops or ointment is placed in the non-amblyopic eye (the eye that is favored by the brain or the sound eye). This causes the sound eye to become unfocused and forces the patient to use the lazy eye.
One type of treatment includes placing a patch over the non-amblyopic eye (the sound eye), which forces the patient to use the lazy eye.
Bangerter foils are another option. The foils, which are made of thin vinyl, are placed over the eye glass lens, covering the non-amblyopic eye. Just like with the patch, this forces the weaker eye to become stronger because you will not be able to see well with the foiled lens.
While there is no way to prevent amblyopia, vision screening can help to detect the condition at an early age. Children aged 3-5 should be screened. Often children less than 3 are also checked for eye problems.
If your child does have amblyopia, they will have a better outcome if treatment is started right away.
American Association for Pediatric Ophthalmology and Strabismus
National Eye Institute (NEI)
Prevent Blindness America
Canadian Ophthalmological Society
The Canadian National Institute for the Blind
Bhola R, Keech RV, Kutschke P, Pfeifer W, Scott WE. Recurrence of amblyopia after occlusion therapy.
. 2006 Nov;113(11):2097-100.
Campos, EC, Schiavi, C, Benedetti, P, et al. Effect of citicoline on visual acuity in amblyopia: preliminary results.
Graefes Arch Clin Exp Ophthalmol
Fleck BW. Amblyopia therapy.
Br J Ophthalmol
. 2003; 87(3):255-6.
Flynn JT, Schiffman J, Feuer W, et al. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies.
Trans Am Ophthalmol Soc
. 1998;96: 431-50; discussion 450-3.
Holmes JM, Beck RW, Kraker RT, et al. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study.
Kushner BJ. Atropine vs. patching for the treatment of moderate amblyopia in children.
LaRoche GR. Amblyopia: detection, prevention, and rehabilitation.
Curr Opin Ophthalmol
Leguire LE, Rogers GL, Walson PD, Bremer DL. Occlusion and levodopa-carbidopa treatment for childhood amblyopia.
Loudon SE, Simonsz HJ. The history of the treatment of amblyopia.
Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
. 2003;110(8):1632-7; discussion 1637-8.
Powell C, Porooshani H, Bohorquez M, et al. Screening for amblyopia in childhood.
Cochrane Database Syst Rev
Ohlsson J, Baumann M, Sjostrand J, et al. Long term visual outcome in amblyopia treatment.
Br J Ophthalmol
. 2002; 86(10):1148-51.
Quinn GE, Beck RW, Holmes JM, et al. Pediatric Eye Disease Investigator Group. Recent advances in the treatment of amblyopia.
. 2004;113 (6):1800-2.
Sakatani K, Jabbur NS, O'Brien TP. Improvement in best corrected visual acuity in amblyopic adult eyes after laser in situ keratomileusis.
J Cataract Refract Surg
Simons K. Amblyopia characterization, treatment, and prophylaxis.
Western Ophthalmics. Bangerter occlusion foils. Western Ophthalmics website. Available at:
http://www.west-op.com/occlusionfoil.html. Accessed May 28, 2010.
5/28/2010 DynaMed's Systematic Literature Surveillance
: Pediatric Eye Disease Investigator Group Writing Committee, Rutstein RP, Quinn GE, et al. A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children.
2/4/2011 DynaMed's Systematic Literature Surveillance
: US Preventive Services Task Force.
Vision screening for children 1 to 5 years of age: US Preventive Services Task Force recommendation statement.
Last Reviewed June 2013